BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Warda ET, Shehata IA, El-ashmawy MB, El-gohary NS. New series of isoxazole derivatives targeting EGFR-TK: Synthesis, molecular modeling and antitumor evaluation. Bioorganic & Medicinal Chemistry 2020;28:115674. [DOI: 10.1016/j.bmc.2020.115674] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu S, Mao Q, Zhong Y, Xue J, Chen B, Zhao Q, Huang W. Highly diastereoselective assembly of isoxazole and trifluoromethyl containing spiro[pyrrolidin-oxindoles] from N-2,2,2-trifluoroethyl-substituted isatin imines and styrylisoxazoles. Tetrahedron Letters 2021;62:152687. [DOI: 10.1016/j.tetlet.2020.152687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Valizadeh S, Ghasemi Z, Shahrisa A, Pirouzmand M, Kabiri R. CuI incorporated magnetic iminochitosan as an efficient catalyst for the synthesis of N-sulfonylamidines possessing 2-formylpyrrole moiety and their subsequent reactions to the synthesis of isoxazole-5-one hybrid derivatives. Reactive and Functional Polymers 2022;171:105172. [DOI: 10.1016/j.reactfunctpolym.2022.105172] [Reference Citation Analysis]
3 Jęśkowiak I, Wiatrak B, Szeląg A, Mączyński M. Preclinical Study of Immunological Isoxazole Derivatives as a Potential Support for Melanoma Chemotherapy. Int J Mol Sci 2021;22:10920. [PMID: 34681580 DOI: 10.3390/ijms222010920] [Reference Citation Analysis]
4 Oubella A, Byadi S, Bimoussa A, Fawzi M, Auhmani A, Podlipnik C, Morjani H, Riahi A, Robert A, Itto MYA. Novel isoxazoline-linked 1,3,4-thiadiazole hybrids as anticancer agents: Design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation. Arch Pharm (Weinheim) 2022;:e2200066. [PMID: 35594031 DOI: 10.1002/ardp.202200066] [Reference Citation Analysis]
5 Talha A, Tachallait H, Benhida R, Bougrin K. Green one-pot four-component synthesis of 3,5-disubstituted isoxazoles- sulfonates and sulfonamides using a combination of NaDCC as metal-free catalyst and ultrasonic activation in water. Tetrahedron Letters 2021;81:153366. [DOI: 10.1016/j.tetlet.2021.153366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bisht S, Kumar L, Kaul G, Akhir A, Saxena D, Chopra S, Karthik R, Goyal N, Batra S. Synthesis and Biological Evaluation of Substituted 3‐Isoxazolethioethers as Antileishmanial and Antibacterial Agents. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202201664] [Reference Citation Analysis]
7 Aissa I, Abdelkafi-Koubaa Z, Chouaïb K, Jalouli M, Assel A, Romdhane A, Harrath AH, Marrakchi N, Ben Jannet H. Glioblastoma-specific anticancer activity of newly synthetized 3,5-disubstituted isoxazole and 1,4-disubstituted triazole-linked tyrosol conjugates. Bioorg Chem 2021;114:105071. [PMID: 34130108 DOI: 10.1016/j.bioorg.2021.105071] [Reference Citation Analysis]
8 Arya GC, Kaur K, Jaitak V. Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies. Eur J Med Chem 2021;221:113511. [PMID: 34000484 DOI: 10.1016/j.ejmech.2021.113511] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Maldonado J, Acevedo W, Molinari A, Oliva A, Knox M, San Feliciano A. Synthesis, in vitro evaluation and molecular docking studies of novel naphthoisoxazolequinone carboxamide hybrids as potential antitumor agents. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2022.2095410] [Reference Citation Analysis]
10 Soltan OM, Shoman ME, Abdel-Aziz SA, Narumi A, Konno H, Abdel-Aziz M. Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy. Eur J Med Chem 2021;225:113768. [PMID: 34450497 DOI: 10.1016/j.ejmech.2021.113768] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]